Open Access

Transforming Outcomes for Patients with hATTR Amyloidosis

Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiac Amyloidosis
Session type: Satellite Symposium
Sponsored by Alnylam Pharmaceuticals
Date: 27 August 2021
Time: 11:30 - 12:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

2 presentations in this session

Transforming Outcomes for Patients with hATTR Amyloidosis.

Speaker: Doctor C. Whelan (London, GB)
Speaker: Doctor O. Akinboboye (New York, US)
Thumbnail

Live Q&A session, Meeting Summary & Close.

Thumbnail

2 speakers from this session

Doctor Carol Whelan

University College London, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Ola Akinboboye

, New York (United States of America)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk